Treatment of premenstrual syndrome by spironolactone: A double‐blind, placebo‐controlled study
The DOI matches its Crossref record.
Abstract
Background. To reevaluate whether spironolactone, a steroid receptor antagonist, is effective in improving premenstrual syndrome (PMS) in a double‐blind, placebo‐controlled cross over study. Methods. Thirty‐five women with PMS were given one tablet of 100 mg spironolactone or placebo daily from day 14 of the menstrual cycle until the first day of the following menstruation. Two pretreatment cycles were observed for diagnosis in each woman, followed by 6 treatment cycles with spironolactone and placebo applied in either the first or second 3 months. The assessment of symptoms and diagnosis of PMS were based on prospective daily self‐ratings made by the women using a validated visual analogue scale. Results. The treatment with spironolactone was associated with an improvement in PMS symptoms compared to placebo as judged by significant decrease in negative mood symptom scores (p < 0.001) and somatic symptom scores (p < 0.001). Of the individual symptoms, spironolactone significantly improved irritability, depression, feeling of swelling, breast tenderness and food craving in comparison to placebo. A lasting effect of spironolactone was observed in women started with spironolactone after cross over to placebo. Conclusions. Spironolactone appears to be an effective therapy for the negative mood changes and somatic symptoms in PMS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder
Yonkers, K. A., Brown, C., Pearlstein, T. B., Foegh, M., Sampson-Landers, C., & Rapkin, A. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000175834.77215.2e · Cited by 349
Sex differences in depression and anxiety disorders: Potential biological determinants
Altemus, M. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.031 · Cited by 312
Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Braverman, P. K. (2007) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2006.10.007 · Cited by 288
Pearlstein, T. B., Bachmann, G. A., Zacur, H. A., & Yonkers, K. A. (2005) · Contraception · doi:10.1016/j.contraception.2005.08.021 · Cited by 279
Oral contraceptives containing drospirenone for premenstrual syndrome
Lopez, L. M., Kaptein, A. A., & Helmerhorst, F. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006586.pub4 · Cited by 270
Metadata
- Authors
- Wang, M., Hammarbäck, S., Lindhe, B., & Bäckström, T.
- Venue
- Acta Obstetricia et Gynecologica Scandinavica
- Publisher
- Wiley
- Published
- 1995-10
- Volume
- 74
- Issue
- 10
- Pages
- 803-808
- ISSN
- 0001-6349 (ISSN-L)
- 1600-0412
- OpenAlex
- W2118407326
- Cited by
- 120
- References
- 0
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of premenstrual syndrome by spironolactone: A double‐blind, placebo‐controlled study. https://app.cochat.ai/papers/10.3109/00016349509021201
- The paper
- Wang, M., Hammarbäck, S., Lindhe, B., & Bäckström, T. (1995). Treatment of premenstrual syndrome by spironolactone: A double‐blind, placebo‐controlled study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.3109/00016349509021201
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.